Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Evidence strongly supports the important role of insulin resistance in cognitive decline and dementia and suggests that insulin sensitizers may protect against cognitive decline in diabetic and pre-diabetic individuals. Inconclusive results have been reported in clinical trials of rosiglitazone, an insulin sensitizer that also increases cardiovascular mortality risks. No study has yet reported a protective cognitive effect of metformin, an insulin-sensitizing biguanide widely used in diabetic patients. We studied 365 older persons aged 55 and over in the population-based Singapore Longitudinal Aging Study with diabetes who were followed up over 4 years. The odds ratios (OR) of association of metformin use (n = 204) versus non-use (n = 161) with cognitive impairment (Mini-Mental State Exam ≤ 23), and by duration: up to 6 years (n = 114) and more than 6 years (n = 90) were evaluated in cross-sectional and longitudinal multivariate analyses. Controlling for age, education, diabetes duration, fasting blood glucose, vascular and non-vascular risk factors, metformin use showed a significant inverse association with cognitive impairment in longitudinal analysis (OR = 0.49, 95% CI 0.25-0.95). Metformin use showed significant linear trends of association across duration of use in cross-sectional and longitudinal analyses (p = 0.018 and p = 0.002, respectively), with use for more than 6 years significantly associated with lowest risk of cognitive impairment in both cross-sectional anal…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although some epidemiological studies supported a protective role for metformin, which crosses the BBB, in preventing cognitive decline in individuals with type 2 diabetes [304]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [304]
In the citing paper
“In the Singapore Longitudinal Aging Study 2,365 subjects with diabetes (age ≥ 55) were monitored for 4 years – see Table 2 (116). In a cross-sectional and longitudinal multivariate analysis, odds ratios of association of the chronic use of metformin with cognitive disability (Mini-Mental State Exam ≤ 23) were evaluated demonstrating a substantial inverse relationship with cognitive impairment (116”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [116]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 2×
“Metformin has also been shown to attenuate inflammation in experimental models of central inflammation by modulating proinflammatory responses in rat primary microglia cells through both AMPK-dependent and AMPK-independent mechanisms [36].”
BackgroundAppendix G: Geriatric Depression Scale
(2015) · Deep Brain Stimulation Management · doi:10.1017/cbo9781316026625.021 · Cited by 1,536
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“This is responsible for the known effects of metformin in inhibiting hepatic glucose production, increasing insulin sensitivity, enhancing peripheral utilization of glucose (from improved insulin binding to insulin receptors), and increasing fatty acid oxidation [31], leading to improved glycemic and lipid profiles fr…”
BackgroundCognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Watson, G. S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 597
Cited by
Items 301–359 of 359
Beşli, N., Ercin, N., Cakmak, R. K., & Kılıç, Ü. (2026) · Pharmaceuticals · doi:10.3390/ph19071072 · Cited by 1
Regulation of Neurogenesis by Organic Cation Transporters: Potential Therapeutic Implications
Ishimoto, T., & Kato, Y. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_445 · Cited by 1
Síndrome de Vogt-Koyanagi-Harada: presentación de un caso clínico.
Freile, M. C. C., & Mendoza, J. P. G. (2015) · Medicina · doi:10.23878/medicina.v19i1.644 · Cited by 1
Bipolar disorder and cardiovascular dysfunction: Mechanisms and implications
Mio, M., & Goldstein, B. I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00019-3 · Cited by 1
Blasimme, A. (2020) · Berghahn Books · doi:10.1515/9781800734982-007 · Cited by 1
Arise, A. K., Malomo, S. A., Omar, S. A., Arubuola, O. V., & Arise, R. O. (2025) · Food Chemistry Advances · doi:10.1016/j.focha.2025.100929 · Cited by 1
โรจนาบุตร, ว., Hemrungrojn, S., Manasvanish, B.-A., & Assawawitoontip, S. (2021) · Journal of Primary Care and Family Medicine (PCFM) · Cited by 1
The relationship between exercise and cognition in diabetes mellitus
Zhao, R. R. (2014) · The Sydney eScholarship Repository (The University of Sydney)
Moyad, M. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-23422-9_6
Kirkland, J. L., & Tchkonia, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_19
Callisaya, M. L., & Moran, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00012-3
Louzada, E. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.89.2017.tde-28112017-160051
Restriction of caloric intake is a key to prevention of vascular ageing
Orlova, Y. A. (2015) · Systemic Hypertension · doi:10.26442/2075-082x_12.2.89-95
Biomarkers of Ceramide Accumulation and Decline in Verbal Memory in Coronary Artery Disease
Chan, P. (2018) · TSpace (University of Toronto)
Epigenetic Regulation of Lipid Metabolism in Neural Stem Cell Fate Decision
Syal, C. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-22958
Ichikawa, O., Glicksberg, B. S., Minsky, N. C., Lee, H.-C., Li, S. D., Chen, R., Li, L., & Dudley, J. T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/814392
Features of diabetes mellitus in very elderly patients
Викторовна, Т. С., Kolontai, T. M., Vaculenko, O. N., & DVORETSKI, L. I. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-1-9(384)-13-19
Pharmacological Cosmetic Neurology
Conrad, E. C., & Chatterjee, A. K. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108554350.017
Darwish, L. (2019) · TSpace (University of Toronto)
Ha, J., Choi, D., Kim, K. J., Cho, S. Y., Kim, H., Kim, K. Y., Koh, Y., Nam, C. M., & Kim, E. (2021) · Research Square · doi:10.21203/rs.3.rs-375444/v1
Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727123638.793572332
Is metformin the only culprit for cognitive impairment in diabetes?
Murali, R., Boloor, A., & Yeshwanth, H. (2023) · F1000Research · doi:10.12688/f1000research.130973.1
Low, S. K. M. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/171362
WITHDRAWN: Intricacies of aging and down syndrome
Kozlov, G., Franceschi, C., & Vedunova, M. V. (2024) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2024.100035
RetractedMetaanalyse zum Zusammenhang zwischen Diabetestherapie und Demenz
Jecht, M. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01164-2
Soldevila‐Domenech, N., Cuenca‐Royo, A., Babió, N., Forcano, L., Nishi, S. K., Vintró‐Alcaraz, C., Martínez, C. G., Jiménez‐Múrcia, S., Fernández-Carrión, R., Gomis‐González, M., et al. (2024) · doi:10.32920/26540974
ANAIS DO II CONGRESSO MÉDICO DE FORMOSA - COMEF
Soares, A. L. R. S., Fernandes, V. A., Tocantins, J. V. A., Grecco, L., & Oliveira, V. G. C. (2024) · doi:10.47094/978-65-6036-611-4.1
Avances en la investigación sobre longevidad: focos actuales y perspectivas futuras
Monje, L. F. C. (2024) · Medicina · doi:10.56050/01205498.2337
Determinants of Cognitive Performance Among Ghanaian Hypertensive Patients: A Cross‐Sectional Study
Gyabaah, S., Nguah, S. B., Asibey, S. O., Ovbiagele, B. I., & Sarfo, F. S. (2025) · Health Science Reports · doi:10.1002/hsr2.71100
Bilder, G. E., & Brown-O’Hara, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-84831-5_10
Thakur, S. (2025) · International Journal of Science and Research (IJSR) · doi:10.21275/sr25725113114
Exploring promising pharmaceutical candidates for antiaging
Nandi, N. K., Lodhi, A., Kumar, D., Lather, V., & Tripathi, P. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00014-6
Targeting insulin resistance to treat cognitive impairment
Miraj, S. S., Benson, R., Malakapogu, P., Shyma, Z., Kurian, S. J., Baral, T., & Shetty, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00018-9
Oxidative stress in brain accelerates the onset of neurodegeneration in hyperglycemic individuals
Rios-Dávila, A. A., Pérez‐Capistran, T., Rodríguez-Vera, D., Mera-Jiménez, E., Rodríguez, M. H., & Soriano-Ursua, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00004-9
Candeias, E. M. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
КОГНИТИВНЫЕ НАРУШЕНИЯ ПРИ САХАРНОМ ДИАБЕТЕ ТИПА 2: РОЛЬ ГИПОГЛИКЕМИЧЕСКОЙ ТЕРАПИИ
Н.В., П. (n.d.) · CyberLeninK (CyberLeninka)
Metformin as a Senotherapeutic Agent
Turgut, Ş., Atasever, E., Andican, G., & Çakatay, U. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-11608-6_16
Real‐world relationship between blood biomarker‐based PhenoAge, metformin, and Alzheimer's disease
Shi, Y., Sun, A., Xu, J., Yang, Y., Saykin, A. J., Cheng, F., & Zhang, P. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70244
The impact of antidiabetic drugs on dementia risk: a Bayesian network meta-analysis
Yu, Y., Peng, X., Su, C., Bai, Y., & Hou, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1780676
Kawalec, P., Bronikowski, K., Ryszkowski, M., Fornal, K., Będkowska-Kuśmierek, N., Zaborowska, S., Pawlak, P., Wojcieszuk, O., Starczewski, Ł., & Babik, A. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.91.70768
Tai, Y., Lee, H., Huang, P.-H., Chen, W. Y., Chien, L., Chan, L., & Hong, C. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261454613
Clementi, E., Carnovale, C., Norata, G. D., & Battini, V. (2024) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
Stratégies thérapeutiques dans le traitement du diabète de type 2
Bordier, L., & Bauduceau, B. (2026) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(25)49531-6
Abdel‐Aal, R. A., Abdelnabi, S., Badary, D. M., & Hussein, A. M. R. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179087
Hart, T., Duke, A., Zhou, Y., Soukas, A. A., & Yerevanian, A. I. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113343
Metformin: Not Just a Diabetes Treatment
Kamdar, D. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm54156
Boşgelmez, İ. İ., Mertaş, B., & Deliser, H. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1871830
Diniz, C. G., Bento-Torres, N. V. O., da Costa, E. R., Magalhães, N. G. D. M., de Melo, M. A. D., Pereira, P. D. C., Carvalho, J. P. R., Magno, G. M., Bento‐Torres, J., Sosthenes, M. C. K., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106922
Autophagy-lysosomal pathway in neurodegeneration
McDonough, S. R., Rao, A. K., McAleer, J. M., Babrowicz, B. M., & Sharma, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00041-0
Maximiano‐Barreto, M. A., Pereira, J. A. D. S., & Bastos‐Silva, V. J. (2026) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2026-0527
P, N. P., S, Godwin Asher Asher, T., Simulia Dhinju, B., & Elayaperumal, S. (2025) · International Journal of Environmental Sciences · doi:10.64252/r7etxv03
窦报敏, Chen, J., Zhao, H., Sun-Yan, A., Zhu, X., & Xu, Y. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109130
Battini, V., Cirnigliaro, G., Leuzzi, R., Rissotto, E., Mosini, G., Benatti, B., Pozzi, M., Nobile, M., Radice, S., Carnovale, C., et al. (2023) · doi:10.3389/fpsyt.2023.1215807.s001
Peng, L., Fang, X., Xu, F., Liu, S., Qian, Y., Gong, X., Zhao, X., Ma, Z., Xia, T., & Gu, X. (2021) · doi:10.3389/fnagi.2021.686506.s002
Zhu, M., Shen, W., Li, J., Jia, N., Xiong, Y., Miao, J., Xie, C., Chen, Q., Shen, K., Meng, P., et al. (2022) · doi:10.3389/fphar.2022.836496.s001
Metadata
- Authors
- Ng, T. P., Feng, L., Yap, K. B., Lee, T. S., Tan, C. H., & Winblad, B.
- Affiliations
- National University of Singapore (SG)
- Karolinska Institutet (SE)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2014-06-04
- Volume
- 41
- Issue
- 1
- Pages
- 61-68
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1597817261
- Cited by
- 334
- References
- 35
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 42 · 2019: 41 · 2018: 23 · 2017: 14 · 2016: 19 · 2015: 12 · 2014: 6
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Cognition Disorders, Cross-Sectional Studies, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents, Longitudinal Studies, Male, Metformin, Middle Aged, Prospective Studies, Singapore, Time Factors, Multivariate Analysis, Linear Models, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.